Theratechnologies to Present at the Canaccord Genuity 42nd Annual Growth Conference
Theratechnologies (NASDAQ: THTX) will participate in the Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022, at 1:00 p.m. ET. Paul Levesque, CEO, will engage in a fireside chat during the event. Interested investors can access the live webcast here, with an archive available for 90 days following the conference.
- None.
- None.
MONTREAL, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer, will participate in a fireside chat at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10, 2022 at 1:00 p.m. ET.
A live webcast of the event can be accessed here and through the investor relations section of the Company’s website under ‘Events’. An archive will also be available for 90 days following the conference.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
FAQ
What is the date and time of the Canaccord Genuity conference for Theratechnologies (THTX)?
Who will represent Theratechnologies at the Canaccord Genuity conference?
How can I access the live webcast of Theratechnologies’ conference presentation?
Will there be a recording available after the Theratechnologies conference?
